Azelaic acid and hair loss: what the 2023 minoxidil comparison study found — and the honest gap between interesting evidence and proven treatment.
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
0:00
|
6:59
From Root to Ritual by Laritelle Organic.
In brief: Azelaic acid is a naturally occurring dicarboxylic acid found in grains and established as a licensed treatment for acne and rosacea. Its use for hair loss is a more recent and more limited story. A 2023 study of 26 women compared 5% azelaic acid to 2% minoxidil for mild female pattern hair loss — both improved hair density and thickness with no statistically significant difference betwe...
Read the full article: https://laritelleorganic.com/blogs/from-root-to-ritual/azelaic-acid-and-hair-loss-what-the-2023-minoxidil-comparison-study-found-and-the-honest-gap-between-interesting-evidence-and-proven-treatment
SPEAKER_00
In brief, azoleic acid is a naturally occurring dicarboxylic acid found in grains and established as a licensed treatment for acne and rosacea. Its use for hair loss is a more recent and more limited story. A 2023 study of 26 women compared 5% azoleic acid to 2% monoxidol for mild female pattern hair loss, both improved hair density and thickness, with no statistically significant difference between groups. A 2015 combination study found azolec acid alongside monoxidyl and tretinoin outperformed monoxidol alone. The honest limitation, the mechanism traces to a 1988 in vitro study, human trials are small and few, and azoleic acid is not licensed or recognized as a hair loss treatment. It is best positioned as a low-risk adjunct, not a standalone treatment. Azoleic acid is well established as a treatment for acne and rosacea. Its use for hair loss is a very different matter. The hair loss rationale is a proposed weak, local inhibition of the enzyme that produces DHT, which is the basis for marketing it as a DHT blocker, but the evidence in hair loss is limited and preliminary, and azoleic acid is not a recognized or licensed treatment for pattern hair loss. My hair.uk clinical review, July 9, 2026. That is the honest baseline from the most recently updated clinical review. Now here is why the ingredient remains worth understanding, despite that baseline, and what the actual human studies show. How does azoleic acid work for hair loss? Azoleic acid operates through Ceva, arrow mechanisms that are all relevant to hair follicle biology. Though with varying degrees of evidence at the human clinical level, 5-alpha reductase inhibition, the DHT mechanism azoleic acid is thought to have some DHT blocking properties, specifically through the inhibition of 5 alpha reductase, the enzyme which converts testosterone to DHT. The evidence for this mechanism traces primarily to a 1988 laboratory in vitro study, not a human clinical trial. The inhibition is described as weak and local, meaning it may reduce DHT at the scalp surface where azoleic acid is applied, without the systemic DHT reduction that phenasteride produces. This is a plausible mechanism that has not been directly confirmed in a well-designed human pharmacokinetic study. Antiinflammatory and antimicrobial activity. Azoleic acid reduces irritation and scalp inflammation, which can worsen hair loss and neutralizes oxidative stress that damages follicles. The antimicrobial properties, well established in acne treatment, include activity against malassessia, the yeast implicated in the PLIF scalp inflammation pathway covered extensively in this series. Antimalseia activity alongside ketoconazole is the most clinically grounded mechanism for azoleic acid scalp benefit, operating independently of the disputed 5AR inhibition. Catalase activation, which may help protect hair follicles against hydrogen peroxide buildup linked to premature thinning, is also proposed. Mino. Zetyl Potentiation. The combination mechanism, research has shown that combining the scientifically proven hair loss treatment monoxidyl with azoleic acid may boost its hair growth results. The proposed mechanism, azoleic acid's anti-inflammatory effect at the scalp surface, may improve monoxidyl's absorption and efficacy by reducing the inflammatory barrier that can impede topical penetration. Additionally, if the 5AR inhibition is real at the scalp level, it would address a different mechanism from monoxidl, making the combination genuinely additive rather than merely duplicative. What do the human studies actually show? The 2023 FPHL comparison study is the most clinically significant finding for female pattern hair loss. A 2023 study explored the effects of azoleic acid versus monoxidol on female pattern hair loss. Twist women with mild pattern hair loss used either 5% azileic acid or 2% topical monoxidol on their scalp twice a day for six months. Both treatments significantly improved hair density and thickness, and there were no noticeable or reported differences between the two treatments. The honest reading of this finding, comparable results to 2% monoxidyl in 26 women is genuinely interesting. It is also 26 women, one of the smallest sample sizes in the hair loss clinical literature. No significant difference between groups at N equals 26 could reflect genuine equivalence or could reflect insufficient statistical power to detect a real difference. The study cannot be trait. TED has definitive evidence that 5% azoleic acid is equivalent to 2% monoxidyl at scale. It is a signal that warrants a larger trial. The 2015 combination study is the stronger design finding. A 2015 study included 46 patients with male pattern baldness. For six months, half used 5% monoxidol alone on their scalp, while the other half used a combination of 5% monoxidol, 1.5% azoleic acid, and 0.01% tretinoin. Both treatments significantly improved hair density and thickness, but the combination produced meaningfully better results. This is the finding that most practically supports azoleic acid's use, not as a standalone treatment replacing monoxidil, but as an adjunct that amplifies monoxidyl's effect. The tretinoin in the combination also improves skin penetration, making it difficult to isolate the azoleic acid contribution. But the direction of effect is clear and consistent. 26 women, 2023 FPHL study. 5% azoleic acid vs 2% minoxidil, 6 months, comparable results. Genuinely interesting, too small to be definitive. Outperformed minoxidil alone vs. monoxidyl plus azoleic acid plus tretinoin. 2015 study of 46 patients. The combination direction is the most practically supported finding. 1988. There is currently an early phase one clinical trial recruiting party.